SWP
PTX

Stratos Wealth Partners’s Pernix Therapeutics Holdings, Inc. PTX Stock Holding History

Stratos Wealth Partners’s Portfolio PTX Stock Details PTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-5
Closed – – 3006
2018
Q3 		$0 Buy
+5
New +$8 ﹤0.01% 3101
2018
Q2 		– Sell
-5
Closed – – 3109
2018
Q1 		$0 Buy
+5
New +$13 ﹤0.01% 3331

Other funds holding PTX

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AC
Aisling Capital New York $45.3M AUM 15.24% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
MFGP
Marshall Financial Group (Pennsylvania) Doylestown, Pennsylvania $364M AUM 12.86% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Cetera Investment Advisers
Cetera Investment Advisers Schaumburg, Illinois $94B AUM 20.14% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Stratos Wealth Partners's PTX Position: Q4 2018 in Review

Stratos Wealth Partners sold out of Pernix Therapeutics Holdings, Inc. (PTX) in Q4 2018, closing a stake of 5 shares.

Stratos Wealth Partners first reported a position in PTX in Q1 2018 and held it in 2 quarters. The position peaked at $0 in Q3 2018. 32 funds tracked by Wall St. Rank hold PTX as of Q4 2018.

  • Stratos Wealth Partners reported no remaining Pernix Therapeutics Holdings, Inc. position as of Q4 2018 after selling out during the quarter.
  • Stratos Wealth Partners sold 5 Pernix Therapeutics Holdings, Inc. shares in Q4 2018.
  • Stratos Wealth Partners first reported a position in Pernix Therapeutics Holdings, Inc. in Q1 2018 and held it in 2 quarters.
  • Stratos Wealth Partners's Pernix Therapeutics Holdings, Inc. position peaked at $0 in Q3 2018.
  • 32 funds tracked by Wall St. Rank held Pernix Therapeutics Holdings, Inc. as of Q4 2018.

Based on Stratos Wealth Partners's 13F filing for Q4 2018, filed 8 Feb 2019.